217 related articles for article (PubMed ID: 35588757)
21. Primary graft function, metabolic control, and graft survival after islet transplantation.
Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
[TBL] [Abstract][Full Text] [Related]
22. Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.
Lablanche S; Borot S; Wojtusciszyn A; Bayle F; Tétaz R; Badet L; Thivolet C; Morelon E; Frimat L; Penfornis A; Kessler L; Brault C; Colin C; Tauveron I; Bosco D; Berney T; Benhamou PY;
Diabetes Care; 2015 Sep; 38(9):1714-22. PubMed ID: 26068866
[TBL] [Abstract][Full Text] [Related]
23. Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.
Forbes S; Oram RA; Smith A; Lam A; Olateju T; Imes S; Malcolm AJ; Shapiro AM; Senior PA
Am J Transplant; 2016 Sep; 16(9):2704-13. PubMed ID: 27017888
[TBL] [Abstract][Full Text] [Related]
24. Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up.
Lehmann R; Graziano J; Brockmann J; Pfammatter T; Kron P; de Rougemont O; Mueller T; Zuellig RA; Spinas GA; Gerber PA
Diabetes Care; 2015 May; 38(5):752-9. PubMed ID: 25665814
[TBL] [Abstract][Full Text] [Related]
25. Estimation of Early Graft Function Using the BETA-2 Score Following Clinical Islet Transplantation.
Lam A; Oram RA; Forbes S; Olateju T; Malcolm AJ; Imes S; Shapiro AMJ; Senior PA
Transpl Int; 2022; 35():10335. PubMed ID: 35874309
[TBL] [Abstract][Full Text] [Related]
26. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients.
Koh A; Imes S; Kin T; Dinyari P; Malcolm A; Toso C; Shapiro AM; Senior P
Transplantation; 2010 Feb; 89(3):361-5. PubMed ID: 20145529
[TBL] [Abstract][Full Text] [Related]
27. Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network.
Lablanche S; Borot S; Wojtusciszyn A; Skaare K; Penfornis A; Malvezzi P; Badet L; Thivolet C; Morelon E; Buron F; Renard E; Tauveron I; Villard O; Munch M; Sommacal S; Clouaire L; Jacquet M; Gonsaud L; Camillo-Brault C; Colin C; Bosson JL; Bosco D; Berney T; Kessler L; Benhamou PY;
Am J Transplant; 2021 Nov; 21(11):3725-3733. PubMed ID: 33961335
[TBL] [Abstract][Full Text] [Related]
28. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
Froud T; Faradji RN; Pileggi A; Messinger S; Baidal DA; Ponte GM; Cure PE; Monroy K; Mendez A; Selvaggi G; Ricordi C; Alejandro R
Transplantation; 2008 Jul; 86(1):36-45. PubMed ID: 18622276
[TBL] [Abstract][Full Text] [Related]
29. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
[TBL] [Abstract][Full Text] [Related]
30. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
Deng S; Markmann JF; Rickels M; Yeh H; Kim JI; Lian MM; Gu Y; Markmann E; Palanjian M; Barker CF; Naji A
Transplantation; 2009 Sep; 88(6):820-5. PubMed ID: 19920782
[TBL] [Abstract][Full Text] [Related]
31. Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft.
Bertuzzi F; Grohovaz F; Maffi P; Caumo A; Aldrighetti L; Nano R; Hengster P; Calori G; Di Carlo V; Bonifacio E; Secchi A
Diabetologia; 2002 Jan; 45(1):77-84. PubMed ID: 11845226
[TBL] [Abstract][Full Text] [Related]
32. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
[TBL] [Abstract][Full Text] [Related]
33. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.
O'Connell PJ; Holmes-Walker DJ; Goodman D; Hawthorne WJ; Loudovaris T; Gunton JE; Thomas HE; Grey ST; Drogemuller CJ; Ward GM; Torpy DJ; Coates PT; Kay TW;
Am J Transplant; 2013 Jul; 13(7):1850-8. PubMed ID: 23668890
[TBL] [Abstract][Full Text] [Related]
34. The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program.
Forbes S; Flatt AJ; Bennett D; Crookston R; Pimkova M; Birtles L; Pernet A; Wood RC; Burling K; Barker P; Counter C; Lumb A; Choudhary P; Rutter MK; Rosenthal M; Sutherland A; Casey J; Johnson P; Shaw JAM
Am J Transplant; 2022 Jan; 22(1):154-164. PubMed ID: 34355503
[TBL] [Abstract][Full Text] [Related]
35. Islet transplantation outcomes in type 1 diabetes and transplantation of HLA-DQ8/DR4: results of a single-centre retrospective cohort in Canada.
Forbes S; Halpin A; Lam A; Grynoch D; Parker R; Hidalgo L; Bigam D; Anderson B; Dajani K; Kin T; O'Gorman D; Senior PA; Campbell P; Shapiro AMJ
EClinicalMedicine; 2024 Jan; 67():102333. PubMed ID: 38169703
[TBL] [Abstract][Full Text] [Related]
36. Pancreas and Islet Transplantation: Comparative Outcome Analysis of a Single-centre Cohort Over 20-years.
Marfil-Garza BA; Hefler J; Verhoeff K; Lam A; Dajani K; Anderson B; O'Gorman D; Kin T; Bello-Chavolla OY; Grynoch D; Halpin A; Campbell PM; Senior PA; Bigam D; Shapiro AMJ
Ann Surg; 2023 Apr; 277(4):672-680. PubMed ID: 36538619
[TBL] [Abstract][Full Text] [Related]
37. Improved outcomes of islet autotransplant after total pancreatectomy by combined blockade of IL-1β and TNFα.
Naziruddin B; Kanak MA; Chang CA; Takita M; Lawrence MC; Dennison AR; Onaca N; Levy MF
Am J Transplant; 2018 Sep; 18(9):2322-2329. PubMed ID: 29862647
[TBL] [Abstract][Full Text] [Related]
38. SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients.
Balke EM; Demeester S; Lee D; Gillard P; Hilbrands R; Van de Velde U; Van der Auwera BJ; Ling Z; Roep BO; Pipeleers DG; Keymeulen B; Gorus FK
Diabetologia; 2018 Jul; 61(7):1623-1632. PubMed ID: 29679103
[TBL] [Abstract][Full Text] [Related]
39. [Kidney and pancreas transplantation: initial experience at a single transplant center in Argentina].
Hyon SH; Groppa R; Pekolj J; Giúdice C; Domenech A; Litwak L; Barcán L; Grosembacher L; Algranati S; Argibay P
Medicina (B Aires); 1999; 59(6):685-92. PubMed ID: 10752209
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States.
Brennan DC; Kopetskie HA; Sayre PH; Alejandro R; Cagliero E; Shapiro AM; Goldstein JS; DesMarais MR; Booher S; Bianchine PJ
Am J Transplant; 2016 Feb; 16(2):509-17. PubMed ID: 26433206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
